
Dupixent CTCL Lawsuits: The Next Emerging MDL
Plaintiffs are moving to centralize Dupixent cutaneous T-cell lymphoma cases as an MDL after the FDA flagged a safety signal.
News and expert insights on medical record retrieval, legal technology, and practice management

Plaintiffs are moving to centralize Dupixent cutaneous T-cell lymphoma cases as an MDL after the FDA flagged a safety signal.

A $10.2M Minnesota verdict and a J&J defense win days apart show why talc cases hinge on decades-long exposure records.

The first formula-linked infant botulism outbreak—48 cases across 19 states—is now a federal MDL in New York.

New York's $268B budget eliminates the 90/180 'serious injury' rule and bars recovery for plaintiffs more than 50% at fault.

AI may make courts faster and more consistent. But if judicial AI is trained to preserve the past, efficiency could hard-code old assumptions into future decisions.

Most PI firms stitch 4-5 vendors together for records. End-to-end platforms collapse authorization, retrieval, analysis, and case analytics into one pipeline.




